3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
31
Lung Neoplasms
11
Head and Neck Neoplasms
5
Breast Neoplasms
3
Adenocarcinoma of Lung
3
Squamous Cell Carcinoma of Head and Neck
2
Skin Neoplasms
2
Prostatic Neoplasms
2
Neoplasms
2
Neoplasm Metastasis
2
Gliosarcoma
2
Glioblastoma
2
Esophageal Neoplasms
2
Carcinoma, Renal Cell
2
Carcinoma
2
Brain Neoplasms
2
Adenocarcinoma Of Esophagus
2
Urinary Bladder Neoplasms
1
Untreated Childhood Anaplastic Astrocytoma
1
Thyroid Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Thyroid Cancer, Papillary
1
Salivary Gland Neoplasms
1
Recurrence
1
Pleural Effusion, Malignant
1
Peritoneal Neoplasms
1
Ovarian Neoplasms
1
Neoplasms, Squamous Cell
1
Lymphoid Interstitial Pneumonia
1
Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer
1
Interventions
pazopanib
4
tazemetostat
3
Doxorubicin
3
cixutumumab
2
Sorafenib
2
Radiotherapy
2
Radiation
2
Interferon-gamma
2
Ifosfamide
2
Gemcitabine
2
tremelimumab
1
temsirolimus
1
sapanisertib
1
romidepsin
1
pembrolizumab
1
lorvotuzumab mertansine
1
liposomal doxorubicin
1
interferon gamma-1b
1
indolepropanol phosphate
1
durvalumab
1
atezolizumab
1
Watchful Waiting
1
Surgical Procedures, Operative
1
Sunitinib
1
Rifampin
1
Razoxane
1
Ramucirumab
1
Radiotherapy, Conformal
1
Observation
1
Leukapheresis
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Sarcoma, Synovial
×
Gefitinib
×
Clear all
No trials found.